These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 9874607)

  • 1. Clodronate in metastatic breast cancer.
    Meli M; Rausa L
    N Engl J Med; 1998 Dec; 339(26):1940; author reply 1941. PubMed ID: 9874607
    [No Abstract]   [Full Text] [Related]  

  • 2. Clodronate in metastatic breast cancer.
    Panasci LC; Sandor V; Melnychuk D
    N Engl J Med; 1998 Dec; 339(26):1940-1; author reply 1941. PubMed ID: 9874608
    [No Abstract]   [Full Text] [Related]  

  • 3. Reduction in new metastases in breast cancer with adjuvant clodronate treatment.
    Diel IJ; Solomayer EF; Costa SD; Gollan C; Goerner R; Wallwiener D; Kaufmann M; Bastert G
    N Engl J Med; 1998 Aug; 339(6):357-63. PubMed ID: 9691101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clodronate in metastatic breast cancer.
    Atkins CD
    N Engl J Med; 1998 Dec; 339(26):1941. PubMed ID: 9874609
    [No Abstract]   [Full Text] [Related]  

  • 5. Should oral bisphosphonates be standard of care in women with early breast cancer?
    Clemons M; Verma S
    Breast Cancer Res Treat; 2005 Apr; 90(3):315-8. PubMed ID: 15830146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bisphosphonates as anticancer drugs.
    Mundy GR; Yoneda T
    N Engl J Med; 1998 Aug; 339(6):398-400. PubMed ID: 9691109
    [No Abstract]   [Full Text] [Related]  

  • 7. [Use of clodronate in the adjuvant treatment of breast cancer is questionable for the time being].
    Elomaa I; Saarto T
    Duodecim; 2001; 117(10):1021-2. PubMed ID: 12116460
    [No Abstract]   [Full Text] [Related]  

  • 8. [Expanding the possibilities of using biphosphonates for prophylaxis and treatment of osteal complications in malignant metastasis].
    Svishchenko IuA; Shimanovskiĭ NL
    Eksp Klin Farmakol; 2004; 67(6):66-71. PubMed ID: 15707020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clodronate treatment influences MMP-2 associated outcome in node positive breast cancer.
    Leppä S; Saarto T; Vehmanen L; Blomqvist C; Elomaa I
    Breast Cancer Res Treat; 2005 Mar; 90(2):117-25. PubMed ID: 15803358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The role of adjuvant clodronate therapy for prevention of bone metastasis in breast cancer].
    Horváth Z
    Magy Onkol; 2002; 46(4):361-4. PubMed ID: 12563361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current and future status of adjuvant therapy for breast cancer.
    Coleman RE
    Cancer; 2003 Feb; 97(3 Suppl):880-6. PubMed ID: 12548590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ten-year follow-up of a randomized controlled trial of adjuvant clodronate treatment in node-positive breast cancer patients.
    Saarto T; Vehmanen L; Virkkunen P; Blomqvist C
    Acta Oncol; 2004; 43(7):650-6. PubMed ID: 15545185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant clodronate in breast cancer.
    Paterson AH
    Acta Oncol; 2005; 44(1):80-2; author reply 83-4. PubMed ID: 15848910
    [No Abstract]   [Full Text] [Related]  

  • 14. Adjuvant bisphosphonates in breast cancer: are we witnessing the emergence of a new therapeutic strategy?
    Coleman RE
    Eur J Cancer; 2009 Jul; 45(11):1909-15. PubMed ID: 19447606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meta-analysis of clodronate and breast cancer survival.
    Ha TC; Li H
    Br J Cancer; 2007 Jun; 96(12):1796-801. PubMed ID: 17325699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clodronate in the prevention and treatment of skeletal metastasis.
    Gulley J; Dahut WL
    Expert Rev Anticancer Ther; 2005 Apr; 5(2):221-30. PubMed ID: 15877520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diphosphonates in solid malignant tumors].
    Kamby C; Pedersen L; Kristensen B
    Ugeskr Laeger; 2005 Jan; 167(4):379-82. PubMed ID: 15719560
    [No Abstract]   [Full Text] [Related]  

  • 18. [Double-blinded controlled study comparing clodronate versus placebo in patients with breast cancer bone metastases].
    Tubiana-Hulin M; Beuzeboc P; Mauriac L; Barbet N; Frenay M; Monnier A; Pion JM; Switsers O; Misset JL; Assadourian S; Bessa E
    Bull Cancer; 2001 Jul; 88(7):701-7. PubMed ID: 11495824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant clodronate treatment does not reduce the frequency of skeletal metastases in node-positive breast cancer patients: 5-year results of a randomized controlled trial.
    Saarto T; Blomqvist C; Virkkunen P; Elomaa I
    J Clin Oncol; 2001 Jan; 19(1):10-7. PubMed ID: 11134190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Double-blind trial of oral clodronate in breast cancer patients with bone metastases].
    Paterson AH; Powles TJ; Kanis JA; McCloskey E; Hanson J; Ashley S
    Bull Cancer; 1993; 80(10 Suppl):50-6. PubMed ID: 8081032
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.